Joydeep Goswami occupies the position of President at Life Technologies Japan Ltd. Dr. Goswami is also on the board of BioLife Solutions, Inc., TMune Therapeutics, Inc. and OncoNano Medicine, Inc. and Chief Strategy & Corporate Development Officer at Illumina, Inc.
He previously occupied the position of Principal at McKinsey & Co., Inc. and President-Clinical Next Generation Sequencing at Thermo Fisher Scientific, Inc. VP-Stem Cell & Regenerative Biology at Invitrogen Corp. and Principal at Life Technologies Corp. (both are subsidiaries of Thermo Fisher Scientific, Inc.).
He received a doctorate, a graduate degree and an MBA from Massachusetts Institute of Technology and an undergraduate degree from Indian Institute of Technology Bombay.
|11/05/2022||638||Derivative/Non-derivative trans. at $217.19 per share.||138,568|
|10/05/2022||165||Derivative/Non-derivative trans. at $218.52 per share.||36,056|
|03/01/2022||2,082||Award at $0 per share.||0|
|02/22/2022||1,521||Derivative/Non-derivative trans. at $319.86 per share.||486,508|
|02/22/2022||3,979||Derivative/Non-derivative trans. at $0 per share.||0|
|11/05/2021||264||Derivative/Non-derivative trans. at $408.14 per share.||107,749|
|10/05/2021||115||Derivative/Non-derivative trans. at $387.98 per share.||44,618|
|02/09/2021||1,380||Award at $0 per share.||0|
|11/05/2020||145||Derivative/Non-derivative trans. at $311.72 per share.||45,200|
|10/05/2020||115||Derivative/Non-derivative trans. at $316.17 per share.||36,360|
|02/05/2020||1,665||Award at $0 per share.||0|
|10/07/2019||1,327||Award at $0 per share.||0|